ELIZABETH BROWN: Open Payments
NPI 1114632445 · EAST BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,332 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $354 · 2025 $1,332
Food & beverage: $1,332
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $262 |
| GlaxoSmithKline, LLC. | 2 | $213 |
| Madrigal Pharmaceuticals | 1 | $140 |
| Hologic Sales and Service, LLC | 1 | $129 |
| Viatris Specialty LLC | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Eisai Inc. | 1 | $122 |
| Phathom Pharmaceuticals, Inc. | 1 | $118 |
| ACADIA Pharmaceuticals Inc | 1 | $101 |
Products named: REZDIFFRA, Yeztugo, APTIMA, YUPELRI, Epclusa, AIRSUPRA, Leqembi, VOQUEZNA.
Industry payments across MA — which companies pay providers there.
